US delays decision on COVID vaccine for children under 5 by at least 2 months - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.

  • 📰 SABCNews
  • ⏱ Reading Time:
  • 36 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 51%

Business News News

Business Business Latest News,Business Business Headlines

A US decision on Pfizer (PFE.N) and BioNTech’s COVID-19 vaccine for children 6 months through 4 years of age has been postponed for at least two months after the Food and Drug Administration said it needed more data.

A medical worker prepares to administer a dose of the coronavirus disease vaccine for 5-11 year old kids [File image]

On Friday, the agency said it had reviewed new trial information that had come in since Pfizer and BioNTech’s request for emergency authorization and decided it needed more data before moving forward. Pfizer and BioNTech had submitted data on the first two doses of what was planned as a three-dose regimen for this age group earlier this month at the request of the FDA. It did not disclose efficacy data.

“This is a three-dose vaccine, and they were going to be presenting data on the first two doses. It makes sense to wait for the safety and efficacy data on all three doses to be available before we make a decision about this vaccine,” said Dr. Paul Offit from Children’s Hospital of Philadelphia.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 37. in BUSİNESS

Business Business Latest News, Business Business Headlines